SYMBIOTEC PHARMALAB LTD Share price

SYMBIOTEC

Small Cap | Pharmaceuticals
₹1149.7
+54.59 (+4.98%)

Stock price as on 21 Sep 2026 at 14:18 PM

Symbiotec pharmalab ltd share price today

Symbiotec Pharmalab Ltd share price is currently at ₹1149.7, which is up by ₹54.59 from its previous closing. Today the stock has fluctuated between ₹...

Symbiotec Pharmalab Ltd stock performance

Today’s low

₹1,104.7

Today’s high

₹1,171

₹1,149.7

52 week low

₹934.2

52 week high

₹1,193.7

₹1,149.7
Open
₹1,104.70
Previous close
₹1,095.10
Share volume
9,48,665
Total traded value (Lakh)
₹10,895.41
Upper circuit
₹1,314.10
Lower circuit
₹876.10

Symbiotec Pharmalab Ltd fundamentals

Market cap (Cr)
₹7,392.30
P/E ratio (TTM)
48.16
Book value per share
₹195.23
Beta
0.85
Return on equity
17.44%
Earnings per share (TTM)
₹22.70
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Symbiotec Pharmalab Ltd technical summary

₹1150.45
+ 5.05 ▲
0
Bearish
16
Bullish
5 Day1,080.3
10 Day1,085.4
12 Day1,093.1
20 Day1,092.9
26 Day1,092.9
50 Day1,092.9
100 Day1,092.9
200 Day1,092.9
5 Day1,079.4
10 Day1,094.1
12 Day1,092.5
20 Day1,092.9
26 Day1,092.9
50 Day1,092.9
100 Day1,092.9
200 Day1,092.9

1083.33

PIVOT

First support
₹0.00
First resistance
₹0.00
Second support
₹0.00
Second resistance
₹0.00
Third support
₹0.00
Third resistance
₹0.00
RSI
49.46
ADX
17.47
MACD
0.18
Williams % R
-38
Commodity Channel Index (CCI)
-48.31
Date
18 Sep 2026
Same day
3,94,025
Week
2,60,555
Month
11,84,853
1 year
0.85
3 years
0.85
Over 1 month
-0.23%
Over 1 year
0%
Over 3 months
0%
Over 3 years
0%
Over 6 months
0%
Over 6 years
0%

Investment Returns

Over 1 Month0.23%
Over 3 Months0%
Over 6 Months0%
Over 1 Year0%

Symbiotec Pharmalab Ltd Shareholding pattern


Public
18.12%
Promoter holdings
33.27%
FII
21.07%
DII
27.51%
Promoter shares
0%
Promoter sharesShareCategory

Satwani Holdings Llp

98,19,885 (15.28%)

Shareholding of Promoter and Promoter Group

Rosewood Investments

90,42,092 (14.07%)

Public Shareholding

Business Excellence Trust Iii - India Business Excellence Fund Iii

65,78,995 (10.24%)

Public Shareholding

Anil Satwani

28,10,896 (4.37%)

Shareholding of Promoter and Promoter Group

Kashish Satwani

27,50,896 (4.28%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Satwani Holdings Llp98,19,885 (15.28%)Shareholding of Promoter and Promoter Group
Rosewood Investments90,42,092 (14.07%)Public Shareholding
Business Excellence Trust Iii - India Business Excellence Fund Iii65,78,995 (10.24%)Public Shareholding
Anil Satwani28,10,896 (4.37%)Shareholding of Promoter and Promoter Group
Kashish Satwani27,50,896 (4.28%)Shareholding of Promoter and Promoter Group
Arjun Anil Satwani Family Trust21,99,104 (3.42%)Shareholding of Promoter and Promoter Group
Krishna Anil Satwani Family Trust21,99,104 (3.42%)Shareholding of Promoter and Promoter Group
Valuequest Founders Conviction Lvf18,76,291 (2.92%)Public Shareholding
Think India Opportunities Master Fund Lp17,71,255 (2.76%)Public Shareholding
Sushil Satwani12,33,938 (1.92%)Shareholding of Promoter and Promoter Group
Dymon Asia Multi-strategy Investment (singapore) Pte. Ltd10,12,145 (1.58%)Public Shareholding
Icici Prudential Smallcap Fund6,62,459 (1.03%)Public Shareholding
Kashish And Anil Satwani Family Trust3,50,000 (0.54%)Shareholding of Promoter and Promoter Group
Swati Sachdev10,000 (0.02%)Shareholding of Promoter and Promoter Group
Sunil Satwani10,000 (0.02%)Shareholding of Promoter and Promoter Group

About SYMBIOTEC PHARMALAB LTD

Symbiotec Pharmalab Private Limited was incorporated as a private limited company, dated September 20, 2002, with the Registrar of Companies, Madhya Pradesh and Chhattisgarh. Subsequently, the name of the Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26, 2025, was issued by the Central Processing Centre. Symbiotec is one of the few companies globally and only Indian manufacturer having continuous manufacturing for progesterone API manufacturing. The Company has its flow chemistr

Parent Organisation

Indian Private

NSE Symbol

SYMBIOTEC

Founded

2002

SYMBIOTEC PHARMALAB LTD CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

VIKSHEN

VIKSIT ENGINEERING LTD.

8.03
+3.78 (+88.94%)
HSIL

HEMANT SURGICAL INDUSTRIES LIM

498
+83 (+20%)
VIKRAMAR

VIKRAM AROMA LIMITED

111.92
+18.65 (+20%)
BILLWIN

BILLWIN INDUSTRIES LIMITED

28.44
+4.74 (+20%)
View all

Top gainers

ETERNAL

ETERNAL LIMITED

335.9
+9.05 (+2.77%)
HCLTECH

HCL TECHNOLOGIES LTD

1281
+31.70 (+2.54%)
ITC

ITC LTD

267
+4.70 (+1.79%)
SUNPHARMA

SUN PHARMACEUTICAL IND L

1868.9
+31.60 (+1.72%)
View all

Top losers

BHARTIARTL

BHARTI AIRTEL LIMITED

1830.2
-63.10 (-3.33%)
ADANIPORTS

ADANI PORT & SEZ LTD

1787.1
-36.90 (-2.02%)
BAJFINANCE

BAJAJ FINANCE LIMITED

1021.3
-19.00 (-1.83%)
POWERGRID

POWER GRID CORP. LTD.

266.1
-4.20 (-1.55%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)